Early intervention for Japanese cedar and cypress pollinosis

Clinical and Experimental Allergy Reviews

Volumn 12, Issue 1, 2012, Pages 10-16

  Yonekura, S ^a   Okamoto, Y ^a   Horiguchi, S ^a   Okubo, K ^b   Gotoh, M ^b   Konno, A ^c   Okuda, M ^b,d  

^a CHIBA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c Southern Tohoku General Hospital and Southern Tohoku Research Institute for Neuroscience   (Japan)

^d Japan Allergy Asthma Clinic   (Japan)

Author keywords

Cedar; Cypress; Cysteinyl leukotriene receptor antagonist; Early intervention; Pollinosis

Indexed keywords

ANTIHISTAMINIC AGENT; CROMOGLYCATE DISODIUM; LORATADINE; PLACEBO; PRANLUKAST; STEROID; TETRYZOLINE; VASOCONSTRICTOR AGENT;

CHAMAECYPARIS; DRUG EFFICACY; EARLY INTERVENTION; HUMAN; JAPANESE CEDAR; JAPANESE CYPRESS; NOSE CONGESTION; OCULAR PRURITUS; POLLEN ALLERGY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHINORRHEA; SCORING SYSTEM; SNEEZING; STEROID THERAPY;

EID: 84857842570     PISSN: 14729725     EISSN: 14729733     Source Type: Journal    
DOI: 10.1111/j.1472-9733.2011.01157.x     Document Type: Review

References (19)

1. Grossman J. One airway, one disease. Chest 1997; 111:11S-16S.
2. Okuda M. Epidemiology of Japanese cedar pollinosis throughout Japan. Ann Allergy Asthma Immunol 2003; 91:288-96.
3. Practical guidelines for the management of allergic rhinitis in Japan - perennial rhinitis and pollinosis - 2005 edition (Fifth revision). Tokyo: Life Science Publishing Co. Ltd., 2005.
4. Kaneko Y, Motohashi Y, Nakamura H et al. Increasing prevalence of Japanese cedar pollinosis: a meta-regression analysis. Int Arch Allergy Immunol 2005; 136:365-71.
5. Ito H, Nishimura J, Suzuki M et al. Specific IgE to Japanese cypress (Chamaecyparis obtusa) in patients with nasal allergy. Ann Allergy Asthma Immunol 1995; 74:299-303.
6. Lipworth BJ. Emerging role of antileukotriene therapy in allergic rhinitis. Clin Exp Allergy 2001; 31:1813-21.
7. Meltzer EO. Clinical evidence for antileukotriene therapy in the management of allergic rhinitis. Ann Allergy Asthma Immunol 2002; 88:23-9.
8. Peters-Golden M, Gleason MM, Togias A. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy 2006; 36:689-703.
9. Fukushima C, Matsuse H, Hishikawa Y et al. Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism. Int Arch Allergy Immunol 2005; 136:165-72.
10. Yonekura S, Okamoto Y, Okubo K et al. Beneficial effects of leukotriene receptor antagonists in the prevention of cedar pollinosis in a community setting. J Investig Allergol Clin Immunol 2009; 19:195-203.
11. Okuda M, Ohkubo K, Goto M et al. Comparative study of two Japanese rhinoconjunctivitis quality-life questionnaires. Acta Otolaryngol 2005; 125:736-44.
12. Okubo K, Gotoh M, Shimada K et al. Effect of fexofenadine on the quality of life of Japanese cedar pollinosis patients. Allergol Int 2004; 53:245-54.
13. Okubo K, Gotoh M, Shimada K et al. Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. Int Arch Allergy Immunol 2005; 136:148-54.
14. Barnes PJ. New directions in allergic diseases: mechanism-based anti-inflammatory therapies. J Allergy Clin Immunol 2000; 106:5-16.
15. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S220-51.
16. Holgate ST, Peters-Golden M, Panettieri RA et al. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003; 111:S18-36.
17. Peters-Golden M, Henderson WR Jr. The role of leukotrienes in allergic rhinitis. Ann Allergy Asthma Immunol 2005; 94:609-18.
18. Tomari S, Matsuse H, Machida I et al. Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumor necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clin Exp Allergy 2003; 33:795-801.
19. Parameswaran K, Watson R, Gauvreau GM et al. The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma. Am J Respir Crit Care Med 2004; 169:915-20.